---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276583583.md"
description: "Novo Nordisk's U.S. stock pre-market fell 11%, while Eli Lilly rose over 4% in pre-market trading. Novo Nordisk's CagriSema performed worse than Eli Lilly's Zepbound in trials"
datetime: "2026-02-23T09:39:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276583583.md)
  - [en](https://longbridge.com/en/news/276583583.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276583583.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/276583583.md) | [繁體中文](https://longbridge.com/zh-HK/news/276583583.md)


# 

Novo Nordisk's U.S. stock pre-market fell 11%, while Eli Lilly rose over 4% in pre-market trading. Novo Nordisk's CagriSema performed worse in trials compared to Eli Lilly's Zepbound

### Related Stocks

- [iShares Global Healthcare ETF (IXJ.US)](https://longbridge.com/en/quote/IXJ.US.md)
- [Novo Nordisk A/S (NVO.US)](https://longbridge.com/en/quote/NVO.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [Defiance Daily Target 2X Long LLY ETF (LLYX.US)](https://longbridge.com/en/quote/LLYX.US.md)
- [Direxion Daily LLY Bear 1X Shares (ELIS.US)](https://longbridge.com/en/quote/ELIS.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)
- [Eli Lilly and Company (LLY.US)](https://longbridge.com/en/quote/LLY.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [iShares US Pharmaceuticals ETF (IHE.US)](https://longbridge.com/en/quote/IHE.US.md)
- [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md)

## Related News & Research

- [Eli Lilly: Foundayo will be available with prescriptions accepted immediately and shipping from April 6](https://longbridge.com/en/news/281395595.md)
- [Herbst Group LLC Makes New Investment in Eli Lilly and Company $LLY](https://longbridge.com/en/news/281706190.md)
- [FACTBOX-Pricing and availability of Novo, Lilly's weight-loss drugs](https://longbridge.com/en/news/281413480.md)
- [Eli Lilly: Eligible Medicare Part D Individuals May Get Foundayo for $50/Month, from as Soon as July 1, 2026](https://longbridge.com/en/news/281395586.md)
- [Traders Buy High Volume of Eli Lilly and Company Call Options (NYSE:LLY)](https://longbridge.com/en/news/281412176.md)